Acuity vs Hubbell
AYI and HUBB side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AYI and HUBB compare
Hubbell is the larger company, worth 2.3 times as much as Acuity ($22.3B against $9.5B).
On earnings, Acuity is cheaper: it trades at 21.1× trailing earnings, against 25.0× for Hubbell.
Hubbell grew revenue faster over the last twelve months (10.6% versus 10.5% for Acuity).
Hubbell keeps more of each dollar of sales as profit, with a net margin of 14.5% compared with 10.3% at Acuity.
Both pay dividends: Acuity yields 0.25% and Hubbell 1.3%.
Acuity scores higher on the StockData Score (21 against 16 for Hubbell), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AYI | HUBB |
|---|---|---|
| Size and price | ||
| Market cap | $9.5B | $22.3B |
| Share price | $318.14 | $422.44 |
| Change, 1 year | −12.0% | −10.6% |
| Change, 5 years | 47.5% | 105% |
| Beta (5Y) | 1.05 | 0.96 |
| Employees | 14K | 18K |
| StockData Score | ||
| Total score | 21 (better) | 16 |
| Valuation score | 3 | 4 (better) |
| Growth score | 3 | 3 |
| Performance score | 6 | 6 |
| Health score | 5 (better) | 1 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 21.1× (better) | 25.0× |
| P/S | 2.1× (better) | 3.6× |
| P/B | 3.3× (better) | 5.7× |
| EV/EBITDA | 11.8× (better) | 18.3× |
| P/FCF | 14.9× (better) | 24.8× |
| PEG | 5.04 | 1.39 (better) |
| FCF yield | 6.7% (better) | 4.0% |
| Fair value | $385.42 | $443.55 |
| Margin of safety | 17.5% (better) | 4.8% |
| Growth | ||
| Revenue growth (TTM) | 10.5% | 10.6% (better) |
| Revenue growth, 5Y average | 5.5% | 9.7% (better) |
| Net income growth (TTM) | 17.6% (better) | 8.4% |
| EPS growth (TTM) | 18.8% (better) | 9.5% |
| EPS growth, 5Y average | 14.9% | 20.8% (better) |
| Profitability | ||
| Gross margin | 49.3% (better) | 35.2% |
| Operating margin | 14.5% | 20.2% (better) |
| Net margin | 10.3% | 14.5% (better) |
| FCF margin | 13.9% | 14.5% (better) |
| Return on equity | 17.4% | 24.4% (better) |
| Return on invested capital | 16.6% (better) | 14.5% |
| Financial health | ||
| Debt / equity | 0.24 (better) | 1.37 |
| Net debt / EBITDA | 0.34 (better) | 3.33 |
| Interest coverage | 18.0× | – |
| Current ratio | 2.05 (better) | 1.61 |
| Altman Z-score | 6.28 (better) | 2.68 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.25% | 1.3% (better) |
| Payout ratio | 4.9% | – |
| Years of dividend growth | 2 | 16 (better) |
| Dividend growth, 5Y average | 4.9% | 7.7% (better) |
| Buyback yield | 2.7% (better) | 0.91% |
| Shareholder yield | 3.0% (better) | 2.3% |
| Ownership | ||
| Held by institutions | 100% | 96.7% |
| Held by insiders | 0.58% | 0.41% |
| Insider net buying, 12 months | −$2.9M (better) | −$20.2M |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 3.1% | 4.9% |
Go deeper
- AYI stock overview
- AYI income statement
- AYI valuation and score
- HUBB stock overview
- HUBB income statement
- HUBB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.